BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10066081)

  • 21. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
    Tworkoski K; Raab-Traub N
    J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.
    Neuzillet Y; Chapeaublanc E; Krucker C; De Koning L; Lebret T; Radvanyi F; Bernard-Pierrot I
    BMC Cancer; 2017 Sep; 17(1):636. PubMed ID: 28882129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
    Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of diet consistency on the expression of insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins during the development of rat masseter muscle soon after weaning.
    Saito T; Fukui K; Akutsu S; Nakagawa Y; Ishibashi K; Nagata J; Shuler CF; Yamane A
    Arch Oral Biol; 2004 Oct; 49(10):777-82. PubMed ID: 15308421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
    Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
    Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor expression in breast cancer epithelium and stroma.
    Cullen KJ; Allison A; Martire I; Ellis M; Singer C
    Breast Cancer Res Treat; 1992; 22(1):21-9. PubMed ID: 1421420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the mannose-6-phosphate/insulin-like growth factor 2 receptor coded by a breast cancer suppressor gene?
    Lemamy GJ; Sahla ME; Berthe ML; Roger P
    Adv Exp Med Biol; 2008; 617():305-10. PubMed ID: 18497053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
    Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
    Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds.
    Ludwig T; Eggenschwiler J; Fisher P; D'Ercole AJ; Davenport ML; Efstratiadis A
    Dev Biol; 1996 Aug; 177(2):517-35. PubMed ID: 8806828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    Choi HJ; Joo HS; Won HY; Min KW; Kim HY; Son T; Oh YH; Lee JY; Kong G
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos.
    Lighten AD; Hardy K; Winston RM; Moore GE
    Mol Reprod Dev; 1997 Jun; 47(2):134-9. PubMed ID: 9136113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
    Browne BC; Eustace AJ; Kennedy S; O'Brien NA; Pedersen K; McDermott MS; Larkin A; Ballot J; Mahgoub T; Sclafani F; Madden S; Kennedy J; Duffy MJ; Crown J; O'Donovan N
    Breast Cancer Res Treat; 2012 Dec; 136(3):717-27. PubMed ID: 23117852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Insulin-like Growth Factor Signalling Pathway in Cardiac Development and Regeneration.
    Díaz Del Moral S; Benaouicha M; Muñoz-Chápuli R; Carmona R
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated free IGF2 levels in localized, early-stage breast cancer in women.
    Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A
    Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coevolution of insulin-like growth factors, insulin and their receptors and binding proteins in New World Monkeys.
    Wallis M
    Growth Horm IGF Res; 2015 Aug; 25(4):158-67. PubMed ID: 26072449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of environmental temperature on IGF1, IGF2, and IGF type I receptor expression in rainbow trout (Oncorhynchus mykiss).
    Gabillard JC; Weil C; Rescan PY; Navarro I; Gutiérrez J; Le Bail PY
    Gen Comp Endocrinol; 2003 Sep; 133(2):233-42. PubMed ID: 12928012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of
    Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K
    Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.